Osteogenesis imperfecta (OI) refers to a group of bone disorders in which certain genetic mutations affect the formation of ...

Data from Phase 3 Orbit and Cosmic studies of setrusumab in osteogenesis imperfecta expected around year-end 2025 ...

Mereo BioPharma Group plc (NASDAQ:MREO) is one of the Best 52-Week Low Penny Stocks to Buy Now. On July 9, Mereo BioPharma ...

But in Nov. 2022, authorities questioned the children, who said their mother would forcibly draw blood from her son, who was ...

A Wish Come True said a child’s wish was granted thanks to money raised from “Pucks for Bucks,” a fundraiser organized by an ...

While tributes pour in for South Africa’s female leaders this Women’s Month, thousands of women with disabilities remain marginalised, battling discrimination, inaccessibility, and a job market that ...

A Crosslake mother will spend decades behind bars for child torture and fraud in what Minnesota Attorney General Keith ...

Q2 2025 Earnings Call Transcript August 6, 2025 Operator: Good afternoon, and welcome to the Ultragenyx Second Quarter 2025 ...

A mother will spend decades in prison after she was sentenced for the torture of her three children, including forcing them to fake illnesses.

Ultragenyx Pharmacutical reported second-quarter revenue increased 13% year over year. The Novato-based company aims for ...

A child maltreatment investigation began in 2022 after Children’s Minnesota hospital in the Twin Cities treated one of the ...

Discover Ultragenyx's Q2 2025 highlights with double-digit revenue growth, pivotal clinical milestones, and confident steps toward profitability by 2027.